UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo

British journal of pharmacology, 2013-03, Vol.168 (6), p.1316-1328

2013

Volltextzugriff (PDF)

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

Biochimica et biophysica acta, 2009-07, Vol.1790 (7), p.702-717

2009

Volltextzugriff (PDF)

Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators

Current medicinal chemistry, 2003-06, Vol.10 (12), p.1035-1049

2003

Volltextzugriff (PDF)

ATP7A is a novel target of retinoic acid receptor β2 in neuroblastoma cells

British journal of cancer, 2009-01, Vol.100 (1), p.96-105

2009

Volltextzugriff (PDF)

Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor Scaffolds

SLAS discovery, 2018-07, Vol.23 (6), p.554-560

2018

Volltextzugriff (PDF)

Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau

Neurobiology of aging, 2019-08, Vol.80, p.11-20

2019

Volltextzugriff (PDF)

Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia

Expert opinion on investigational drugs, 2000-06, Vol.9 (6), p.1257-1270

2000

Volltextzugriff (PDF)

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

Current drug delivery, 2010-07, Vol.7 (3), p.194-207

2010

Volltextzugriff (PDF)

Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity

Journal of medicinal chemistry, 2006-11, Vol.49 (22), p.6510-6521

2006

Volltextzugriff (PDF)

2-Hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone

Acta crystallographica. Section C, Crystal structure communications, 2000-03, Vol.56 (3), p.341-342

2000

Volltextzugriff (PDF)

Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents

Journal of medicinal chemistry, 2007-07, Vol.50 (15), p.3716-3729

2007

Volltextzugriff (PDF)

Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load

Journal of Alzheimer's disease, 2020-01, Vol.76 (1), p.291-301

2020

Volltextzugriff (PDF)

Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment

Blood, 2004-09, Vol.104 (5), p.1450-1458

2004

Volltextzugriff (PDF)

Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites

The international journal of biochemistry & cell biology, 2004-03, Vol.36 (3), p.401-407

2004

Volltextzugriff (PDF)

Novel “hybrid” iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells

Blood, 2002-07, Vol.100 (2), p.666-676

2002

Volltextzugriff (PDF)

Examination of the antiproliferative activity of iron chelators: Multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311

Clinical cancer research, 2003, Vol.9 (1), p.402-414

2003

Volltextzugriff (PDF)

Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents

British journal of pharmacology, 2003-03, Vol.138 (5), p.819-830

2003

Volltextzugriff (PDF)

ATP7A is a novel target of retinoic acid receptor beta sub(2) in neuroblastoma cells

British journal of cancer, 2009-01, Vol.100 (1), p.96-105

2009

Volltextzugriff (PDF)

ATP7A is a novel target of retinoic acid receptor [beta]2 in neuroblastoma cells

British journal of cancer, 2009-01, Vol.100 (1), p.96

2009

Volltextzugriff (PDF)

Novel di-2-pyridyl-derived iron chelators with marked and selective antitumour activity: in vitro and in vivo assessment

European journal of clinical investigation, 2004-04, Vol.34, p.41

2004

Volltextzugriff (PDF)

The Osler medal essay: The hospital and society: the growth of hospitals in Rochester, New York, in the nineteenth century

Bulletin of the history of medicine, 1975-12, Vol.49 (4), p.536-555

Lovejoy, Jr, D B

1975

Volltextzugriff (PDF)

Environmental Genotoxicity in Klaipėda Port Area

International review of hydrobiology., 2000-11, Vol.85 (5-6), p.663-672

2000

Volltextzugriff (PDF)

ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells

British journal of cancer, 2009-01, Vol.100 (1), p.96-105

2009

Volltextzugriff (PDF)

PCTH: A Novel Orally Active Chelator for the Treatment of Iron Overload Disease

Hemoglobin, 2006, Vol.30 (1), p.93-104

2006

Volltextzugriff (PDF)

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

Current drug delivery, 2010-07, Vol.7 (3), p.194

2010

Volltextzugriff (PDF)

1 – 25 von 198

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(166)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(198)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(77)
Humans
(64)
Biological And Medical Sciences
(31)
Physical Sciences
(29)
Animals
(28)
Female
(27)
Male
(23)
Exact Sciences And Technology
(20)
Physics
(20)
Medical Sciences
(19)
Biochemistry & Molecular Biology
(18)
Science & Technology - Other Topics
(16)
Molecular Sequence Data
(15)
Multidisciplinary Sciences
(15)
Amino Acid Sequence
(14)
Middle Aged
(14)
Technology
(14)
Aged
(13)
Fundamental And Applied Biological Sciences. Psychology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo

Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents

Iron chelators as anti-neoplastic agents: current developments and promise of the PIH class of chelators

ATP7A is a novel target of retinoic acid receptor β2 in neuroblastoma cells

Development of a Rapid Fluorescence-Based High-Throughput Screening Assay to Identify Novel Kynurenine 3-Monooxygenase Inhibitor Scaffolds

Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau

Complexes of gallium(III) and other metal ions and their potential in the treatment of neoplasia

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

Dipyridyl Thiosemicarbazone Chelators with Potent and Selective Antitumor Activity Form Iron Complexes with Redox Activity

2-Hydroxy-1-naphthaldehyde 2-methylthiosemicarbazone

Design, Synthesis, and Characterization of Novel Iron Chelators: Structure−Activity Relationships of the 2-Benzoylpyridine Thiosemicarbazone Series and Their 3-Nitrobenzoyl Analogues as Potent Antitumor Agents

Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load

Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment

Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites

Novel “hybrid” iron chelators derived from aroylhydrazones and thiosemicarbazones demonstrate selective antiproliferative activity against tumor cells

Examination of the antiproliferative activity of iron chelators: Multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311

Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents

ATP7A is a novel target of retinoic acid receptor beta sub(2) in neuroblastoma cells

ATP7A is a novel target of retinoic acid receptor [beta]2 in neuroblastoma cells

Novel di-2-pyridyl-derived iron chelators with marked and selective antitumour activity: in vitro and in vivo assessment

The Osler medal essay: The hospital and society: the growth of hospitals in Rochester, New York, in the nineteenth century

Environmental Genotoxicity in Klaipėda Port Area

ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells

PCTH: A Novel Orally Active Chelator for the Treatment of Iron Overload Disease

Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity

Suchergebnisse filtern